Evidence map›Paper›PMID 34556855›Full record

ArticleNature microbiology2021

Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy.

Laura Martin-Sancho, Shashank Tripathi, Ariel Rodriguez-Frandsen, Lars Pache, Maite Sanchez-Aparicio, Michael J McGregor, Kelsey M Haas, Danielle L Swaney, Thong T Nguyen, João I Mamede and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Multi-omics to study chronic respiratory diseases and viral infections.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Virus infection and vesicle trafficking.Frontiers in immunology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 9 institutions in 2 countries.

Laura Martin-SanchoImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Shashank TripathiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ariel Rodriguez-FrandsenImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Lars PacheImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4193-1042
Maite Sanchez-AparicioDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-6556-5924
Michael J McGregorQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.
Kelsey M HaasQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-1463-6726
Danielle L SwaneyQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.
Thong T NguyenQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.
João I MamedeDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6048-1876
Christopher ChurasDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Dexter PrattDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Sara B RosenthalDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Laura RivaImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Courtney NguyenImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Nish Beltran-RaygozaImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Stephen SoonthornvacharinImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Guojun WangDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
David Jimenez-MoralesQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4356-6461
Paul D De JesusImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Hong M MoultonDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
David A SteinDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Max W ChangDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4526-489X
Chris BennerDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4618-0719
Trey IdekerDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1708-8454
Randy A AlbrechtDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-4008-503X
Judd F HultquistDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
Nevan J KroganQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4902-337X
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-6551-1827
Sumit K ChandaImmunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. schanda@sbpdiscovery.org.ORCID http://orcid.org/0000-0001-9399-7927
Sanford Burnham Prebys Medical Discovery Institute · USGladstone Institutes · USUniversity of California San Diego · USIcahn School of Medicine at Mount Sinai · USOregon State University · USIndian Institute of Science Bangalore · INNorthwestern University · USRush University Medical Center · USTisch Hospital · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SHAW, MEGAN LOUISE · 2013 to 2017
$26.0M
RESEARCH PROJECT 2U19AI135990 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Melanie Maria Ott · 2018 to 2026
$21.4M
TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
Project I: Immunity to Influenza in Primary Lung Epithelial CellsU19AI117873 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SEALFON, STUART C. · 2015 to 2019
$8.6M
The Influence of Early Integration Events on HIV Latency and Reactivation PotentialK22AI136691 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULTQUIST, JUDD F · 2018 to 2019
$269k
NCI NIH HHS P30 CA030199NIAID NIH HHS HHSN272201400008CNIAID NIH HHS K22 AI136691NIAID NIH HHS U19 AI106754NIAID NIH HHS U19 AI117873NIAID NIH HHS U19 AI135972NIAID NIH HHS U19 AI135990NIGMS NIH HHS P41 GM103504
6 · The paper itself

Abstract

The fate of influenza A virus (IAV) infection in the host cell depends on the balance between cellular defence mechanisms and viral evasion strategies. To illuminate the landscape of IAV cellular restriction, we generated and integrated global genetic loss-of-function screens with transcriptomics and proteomics data. Our multi-omics analysis revealed a subset of both IFN-dependent and independent cellular defence mechanisms that inhibit IAV replication. Amongst these, the autophagy regulator TBC1 domain family member 5 (TBC1D5), which binds Rab7 to enable fusion of autophagosomes and lysosomes, was found to control IAV replication in vitro and in vivo and to promote lysosomal targeting of IAV M2 protein. Notably, IAV M2 was observed to abrogate TBC1D5-Rab7 binding through a physical interaction with TBC1D5 via its cytoplasmic tail. Our results provide evidence for the molecular mechanism utilised by IAV M2 protein to escape lysosomal degradation and traffic to the cell membrane, where it supports IAV budding and growth.

Indexed as

AutophagyImmune EvasionAntiviral AgentsGTPase-Activating ProteinsHost-Pathogen InteractionsHumansInfluenza A virusLysosomesProtein Bindingrab7 GTP-Binding Proteinsrab GTP-Binding ProteinsViral Matrix ProteinsViroporin ProteinsVirus ReplicationAntiviral AgentsGTPase-Activating ProteinsM2 protein, Influenza A virusrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanrab GTP-Binding ProteinsTBC1D5 protein, humanViral Matrix ProteinsViroporin Proteins

Identifiers

PMID34556855
PMCPMC9683089
OpenAlexW3201584863

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.